CSIMarket
 


Celgene Corp  (CELG)
Other Ticker:  
 


Celgene's ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Celgene's ROI in the third quarter of 2019?
Celgene Corp achieved a return on average invested assets (ROI) of 5.36 % in its third quarter of 2019, which is below Celgene's average return on investment, which stands at 6.03%.

ROI has improved compared to 3.74% in the second quarter of 2019, due to net income growth.

Within the Healthcare sector 146 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 1186 to 1633.

Definition and Formula of Return on Investment


Return On Investment (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Investment Change 19.07 % 22.65 % 7.13 % 15.72 % -
Y / Y Net Income Change 56.28 % 50.33 % 82.62 % - 9.51 %
Investment (TTM) in Millions 36,354 35,498 33,684 31,423 30,532
Return On Investment (TTM) 5.36 % 3.74 % 2.24 % 0 % -0.06 %
CELG's Overall Ranking # 1633 # 1186 # 1579 # 0 # 0
Seq. Investment Change 2.41 % 5.39 % 7.2 % 2.92 % 5.49 %
Seq. Net Income Change 7.64 % 1.68 % - - 3.54 %
Net Income (TTM) in Millions 1,834 1,225 699 0 -17




Return On Investment CELG's Ranking
Within: No.
Industry # 54
Sector # 147
Overall # 1633

Return On Investment Statistics
High Average Low
18.86 %
6.03 %
-49.9 %
(March 31, 2010)   (March 31, 2008)







Financial Statements
Celgene's III. Quarter Investments $ 36,354 Millions CELG's Balance sheet
Celgene's III. Quarter Income $ 1,691 Millions Quarterly CELG's Income Statement
CELG's Income by Division See CELG's Income by Division


CELG Annual Return On Investment (Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
(Dec 31 2015)
2015
(FY 2014)
(Dec. 31, 2014)
Total Investments in Millions 31,423 27,154 22,607 22,565 15,228
Y / Y Investment Growth 15.72 % 20.11 % 0.19 % 48.18 % 33.2 %
Net Income in Millions 4,046 2,940 1,999 1,602 2,000
Y / Y Net Income Growth 37.62 % 47.06 % 24.79 % -19.9 % 37.93 %
Annual Return On Investment 12.88 % 10.83 % 8.84 % 7.1 % 13.13 %


Annual Roi Comment
In the fiscal year 2018 ROI improved to 12.88 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CELG's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for CELG's Competitors
Roi for Celgene's Suppliers
Return On Investment for CELG's Customers

Other Ratios
CELG's Roa CELG's Inventory Turnover Ratio CELG's Growth Rates CELG's Dividend Statistics
CELG's Profitability Ratios CELG's Asset Turnover Ratio CELG's Dividend Growth
CELG's Roe CELG's Valuation Ratios CELG's Financial Strength Ratios CELG's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI
Ionis Pharmaceuticals Inc  14.69 %
Merck and Co Inc   14.63 %
Agilent Technologies inc   14.22 %
Adaptive Biotechnologies Corporation  14.21 %
Utah Medical Products Inc  14.03 %
Pacific Health Care Organization Inc   13.92 %
Psychemedics Corporation  13.88 %
Fresenius Medical Care Ag  13.67 %
Escalon Medical Corp   13.62 %
Lemaitre Vascular Inc   13.57 %
West Pharmaceutical Services Inc   12.98 %
Steris Plc  12.78 %
Medpace Holdings Inc   12.74 %
U S Physical Therapy Inc  12.69 %
Pfizer Inc  12.59 %
Bruker Corporation  12.01 %
Jazz Pharmaceuticals Plc  12.00 %
Supernus Pharmaceuticals inc   11.94 %
Resmed Inc   11.79 %
Ufp Technologies Inc   11.71 %
Johnson and Johnson  11.63 %
Globus Medical Inc   11.43 %
Electromed Inc   11.20 %
Hca Healthcare Inc   11.17 %
Alexion Pharmaceuticals Inc   11.01 %
Anika Therapeutics Inc   10.75 %
Healthcare Services Group Inc   10.59 %
Quidelortho Corp  10.43 %
Enanta Pharmaceuticals Inc  10.35 %
Koru Medical Systems Inc  10.31 %


Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com